Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Capecitabine Tablets
Indication: FDA approved for the treatment of metastatic breast cancer that is resistant to conventional therapies and for the treatment of metastatic colorectal cancer in combination with Taxotere for the treatment of advanced breast cancer.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Qingdao Jinfeng Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Chengdu Beite Denuo Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Harbin Medisan Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Hubei Ouli Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Xiao Cancer Tablets
Manufacturer:
Xianyang Jinxiang Pharmaceutical Co., Ltd.
Compound Cantharides Capsules
Manufacturer:
Guizhou Yibai Pharmaceutical Co., Ltd.
Related Ingredients
-
Capecitabine list
154361-50-9 -
Tegafur list
17902-23-7 -
1,10-Phenanthroline hydrate list
5144-89-8